These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 17198082

  • 1. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML, Kadima AN, El-Naggar SA, Rubinstein MP, Chen Y, Gillanders WE, Cole DJ.
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [Abstract] [Full Text] [Related]

  • 2. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
    Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E.
    Cancer Res; 2007 Jan 01; 67(1):371-80. PubMed ID: 17210720
    [Abstract] [Full Text] [Related]

  • 3. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 4. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 5. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 15; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 6. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA, von Wasielewski R, Gamrekelashvili J, Krüger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF.
    Gastroenterology; 2008 Sep 15; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [Abstract] [Full Text] [Related]

  • 7. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T, Wall EM, Milne K, Theiss P, Watson P, Nelson BH.
    Clin Cancer Res; 2007 Dec 01; 13(23):7172-80. PubMed ID: 18056198
    [Abstract] [Full Text] [Related]

  • 8. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Oct 01; 48(10):4795-801. PubMed ID: 17898306
    [Abstract] [Full Text] [Related]

  • 9. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C.
    Prostate; 2006 Feb 15; 66(3):235-47. PubMed ID: 16173028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
    Han YW, Aleyas AG, George JA, Yoon HA, Lee JH, Kim BS, Eo SK.
    J Microbiol Biotechnol; 2007 Dec 15; 17(12):1955-64. PubMed ID: 18167442
    [Abstract] [Full Text] [Related]

  • 13. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration.
    Wells JW, Cowled CJ, Giorgini A, Kemeny DM, Noble A.
    J Allergy Clin Immunol; 2007 Jan 15; 119(1):226-34. PubMed ID: 17208606
    [Abstract] [Full Text] [Related]

  • 14. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG, Schuurhuis DH, Fu N, Camps M, van Duivenvoorde LM, Louis-Plence P, Franken KL, Huizinga TW, Melief CJ, Toes RE, Ossendorp F.
    Eur J Immunol; 2009 Jul 15; 39(7):1765-73. PubMed ID: 19544486
    [Abstract] [Full Text] [Related]

  • 15. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE, Redmond WL, Haley D, Weinberg AD.
    Eur J Immunol; 2007 Jan 15; 37(1):157-66. PubMed ID: 17183611
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.
    Cell Res; 2007 Jul 15; 17(7):627-37. PubMed ID: 17563757
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J, Rolinski J, Hus I, Dmoszynska A, Wiesneth M, Schmitt M.
    Int J Oncol; 2006 Apr 15; 28(4):855-61. PubMed ID: 16525634
    [Abstract] [Full Text] [Related]

  • 19. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B, Navabi H, Adams M.
    Vaccine; 2009 May 26; 27(25-26):3401-4. PubMed ID: 19200817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.